Hebei Zhanshun Technology Co., Ltd., a leading manufacturer and supplier of pharmaceutical products in China, is proud to introduce its latest product - Arg(34)Glp-1(7-37) peptide.
Arg(34)Glp-1(7-37) is a glucagon-like peptide-1 (GLP-1) analogue that is currently being investigated for the treatment of various metabolic disorders such as type 2 diabetes and obesity. GLP-1 is a naturally occurring peptide hormone that stimulates insulin secretion and has important glucose-lowering effects.
This novel peptide is designed to provide improved pharmacokinetic characteristics, such as longer half-life and greater stability, compared to endogenous GLP-1. It is also expected to have fewer side effects and a more consistent glycemic control profile in patients.
Hebei Zhanshun Technology Co., Ltd. is committed to delivering high-quality and innovative pharmaceutical products to meet the needs of patients worldwide. With our state-of-the-art facilities and experienced team, we are confident in the safety and efficacy of our products, including Arg(34)Glp-1(7-37).